Population Health Learning Network

As we near Election Day, the Supreme Court faces key decisions that will influence election administration for years to come. Their rulings in RNC v. Genser and Beals v. Virginia Coalition for Immigrant Rights could reshape the relationship between state and federal courts, impacting both the democratic process and broader policy issues like healthcare. Check out our latest Behind the Bill post for more ⬇ #BehindtheBill #HMPMarketAccessInsights #Election2024 #SupremeCourt #HealthcarePolicy

News from First Report Managed Care: Alex Spira, MD, PhD, FACP, FASCO, Virginia Cancer Specialists, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC) and the rise of EGFR mutations in patients with lung cancer. Check out the full video interview here: https://lnkd.in/eJ6ymmZ8 #FirstReportManagedCare #FRMC #LungCancer #NonSmallCellLungCancer #CancerCare #Ongology

News from Veterans Health Today: New Findings on Pembrolizumab + Radiotherapy for Metastatic Urothelial Carcinoma The ARON-2 real-world study, recently published in Scientific Reports, reveals that combining pembrolizumab with radiotherapy, specifically stereotactic body radiotherapy (SBRT), significantly improves overall survival for patients with metastatic urothelial carcinoma (mUC) who progressed after platinum-based chemotherapy. Study findings underscore the potential of SBRT to enhance disease control and survival in this challenging patient population. #VeteransHealthToday #PACTAct #oncology #urothelialcarcinoma #pembrolizumab #radiotherapy #cancerresearch #healthcare

News from First Report Managed Care: In this interview, Stephen Vaccaro, president at HHAeXchange, talks about the impact of the 2024 Homecare Insights Survey on caregiver satisfaction and how specialized training, recognition, and technology can enhance patient care and support caregiver well-being. Click here to read the full interview: https://lnkd.in/eSp8MniE #FirstReportManagedCare #FRMC #Homecare #Carefivers

News from First Report Managed Care: Researchers at AMCP Nexus 2024 explored the cost-effectiveness of Midomafetamine-assisted therapy (MDMA-AT) for post-traumatic stress disorder (PTSD) in US health care settings, with findings suggesting it may be a more cost-effective treatment option than therapy alone. #FirstReportManagedCare #FRMC #AMCPNexus #MDMAAT #PTSD 

News from Annals of Long-Term Care: Personalized adaptive deep brain stimulation may offer better control of motor symptoms and enhance quality of life compared to standard treatment approaches in Parkinson disease. #AnnalsofLongTermCare #ALTC #parkinsondisease #PD #DBS 

Calling all health care professionals! 📢 Are you a passionate expert with experience in CMS policies, payer coverage, health care legislation, or specialized therapeutic areas? First Report Managed Care wants to hear from you! First Report Managed Care is seeking thought leaders to contribute to meaningful discussions that will shape the future of health care. Interested in joining the conversation? Reach out to Danielle Sposato, Assistant Editorial Director (dsposato@hmpglobal.com) to learn more. #HealthcarePolicy #PayerCoverage #TherapeuticAreas #FirstReportManagedCare #HealthcareInnovation

News from Veterans Health Today: The US Department of Veterans Affairs has announced nationwide availability of tele-emergency care (tele-EC), providing veterans with timely virtual emergency care options and improving access to world-class care. #VeteransHealthToday #USDepartmentofVeteransAffairs #VA #VeteransHealth #tele-ec #virtualcare

With the 2024 elections just 13 days away, everyone has one question: What happens next? From potential changes to the ACA to the unpredictable polling data, this election could reshape how Americans access care. Navigating this evolving landscape requires staying informed and adaptable. Dive deeper into what this means for the future of healthcare in our latest Behind the Bill ⬇ #HMPMarketAccessInsights #HealthPolicy #2024Elections #BehindTheBill #HealthcareReform

News from Pharmacy Learning Network: SGLT2 inhibitors have emerged as a gold standard medication for treating patients with heart failure (HF), regardless of the patient’s ejection fraction. These medications have consistently demonstrated the ability to reduce the risk of hospitalization and extend survival in patients with symptomatic HF. In this installment of Talking Therapeutics, explore a first-of-its-kind trial evaluating the potential of SGLT2 inhibitors to prevent chemotherapy-related cardiotoxicity. #PharmacyLearningNetwork #PLN #SGLT2inhibitors #cardiotoxicity #heartfailure #diabetes